Stay updated on Sasanlimab in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the Sasanlimab in Advanced Malignancies Clinical Trial page.

Latest updates to the Sasanlimab in Advanced Malignancies Clinical Trial page
- Check5 days agoChange DetectedThe page has been updated to reflect a new version, v2.16.8, of the HHS Vulnerability Disclosure, replacing the previous version v2.16.6.SummaryDifference0.1%
- Check12 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.1%
- Check19 days agoChange DetectedA service alert has been added indicating planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference0.7%
- Check27 days agoChange DetectedThe webpage has updated the number of study locations from 42 to 48 and added several new medical centers in Saint Petersburg, while also removing outdated dates and a previous revision note.SummaryDifference4%
- Check34 days agoNo Change Detected
- Check41 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.7%
- Check48 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
Stay in the know with updates to Sasanlimab in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sasanlimab in Advanced Malignancies Clinical Trial page.